What is the primary objective of the 2023 Senior Officer PEP?

The primary objective of the Senior Officer PEP is to incentivize and reward executive officers for achieving specific financial and operational performance targets, thereby aligning their compensation with the company's strategic goals and shareholder value creation. It emphasizes both profitability (EBITDA) and patient care quality.

How are executive bonuses determined under this new program?

Executive bonuses are determined based on a weighted formula: 80% of the award is tied to achieving specified EBITDA targets (a combination of company-wide and group-specific performance), and 20% is tied to meeting targets in key quality metrics related to patient care.

What happens if HCA's EBITDA performance is below a certain level?

If HCA's actual EBITDA is less than 90% of the target level, no payment will be made with respect to the quality-weighted portion of the Senior Officer PEP awards. Additionally, no payments will be made for performance below specified threshold amounts for the EBITDA component.

Are there any provisions for recovering awarded compensation?

Yes, awards made under the Senior Officer PEP are subject to clawback or adjustment by the company under certain circumstances, such as restatements of financial results or participant conduct that materially harms the business. Awards are also subject to mandatory repayment in situations specified within the program document.

HCA 8-K: Leadership Changes

Summary

HCA Healthcare, Inc. (HCA) has filed an 8-K detailing its new 2023 Senior Officer Performance Excellence Program (Senior Officer PEP). This program outlines the incentive compensation structure for the company's executive officers, with awards weighted 80% towards EBITDA targets and 20% towards quality metrics. The program aims to align executive compensation with both financial performance and patient care quality. Key features include tiered payout structures for performance against targets, with specific award opportunities outlined for the CEO, CFO, COO, and Chief Legal Officer, expressed as percentages of their base salaries. The program also includes provisions for adjustments, clawbacks in certain circumstances, and is payable in cash. Investors should note the emphasis on EBITDA and specific quality indicators, which provides insight into HCA's strategic priorities for executive performance in 2023.

Key Highlights

1HCA established the 2023 Senior Officer Performance Excellence Program (Senior Officer PEP) effective April 3, 2023.
2Executive compensation under the Senior Officer PEP is weighted 80% on EBITDA targets and 20% on quality metrics.
3Specific target award opportunities are defined as a percentage of base salary for named executive officers: CEO (170%), CFO (125%), COO (125%), and Chief Legal Officer (85%).
4The EBITDA component is split, with 50% company-wide EBITDA and 50% group-specific EBITDA for certain Presidents.
5Quality metrics include Healthcare-Associated Infections and Sepsis (30%), Complication and Mortality (30%), and Care Experience (40%).
6Performance payouts range from 25% of target award for threshold performance to 200% for maximum performance, with straight-line interpolation for results between threshold and target/maximum.
7Awards are payable in cash and are subject to clawback or adjustment provisions under specific conditions, including EBITDA below 90% of target or restatements of financial results.

HCA Healthcare, Inc. 8-K Report, Executive Changes (Apr 6, 2023)

Summary

Key Highlights

Frequently Asked Questions